Abstract: Annals of the New York Academy of SciencesVolume 447, Issue 1 p. 297-313 Biotin Status of Epilepticsa KLAUS-HENNING KRAUSE, KLAUS-HENNING KRAUSE Neurologische Universitätsklinik Voss-Str. 2 D-6900 Heidelberg, Federal Republic of GermanySearch for more papers by this authorJEAN-PIERRE BONJOUR, JEAN-PIERRE BONJOUR Department of Vitamin and Nutrition Research F. Hoffmann-La Roche & Co. Ltd. CH-4002 Basel, SwitzerlandSearch for more papers by this authorPETER BERLIT, PETER BERLIT Neurologische Universitätsklinik Voss-Str. 2 D-6900 Heidelberg, Federal Republic of GermanySearch for more papers by this authorWALTER KOCHEN, WALTER KOCHEN Universitäts-Kinderklinik Im Neuenheimer Feld 153 D-6900 Heidelberg, Federal Republic of GermanySearch for more papers by this author KLAUS-HENNING KRAUSE, KLAUS-HENNING KRAUSE Neurologische Universitätsklinik Voss-Str. 2 D-6900 Heidelberg, Federal Republic of GermanySearch for more papers by this authorJEAN-PIERRE BONJOUR, JEAN-PIERRE BONJOUR Department of Vitamin and Nutrition Research F. Hoffmann-La Roche & Co. Ltd. CH-4002 Basel, SwitzerlandSearch for more papers by this authorPETER BERLIT, PETER BERLIT Neurologische Universitätsklinik Voss-Str. 2 D-6900 Heidelberg, Federal Republic of GermanySearch for more papers by this authorWALTER KOCHEN, WALTER KOCHEN Universitäts-Kinderklinik Im Neuenheimer Feld 153 D-6900 Heidelberg, Federal Republic of GermanySearch for more papers by this author First published: June 1985 https://doi.org/10.1111/j.1749-6632.1985.tb18447.xCitations: 49 a Dedicated to Professor H. Ganshirt, Director of the Neurological Clinic, University of Heidelberg on the occasion of his 65th birthday. This work was supported in part by Grant Kr 659/1 from the Deutsche Forschungsgemeinschaft. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Reference 1 Johnston, D. & G. E. Slater. 1982. Valproate, Mechanism of action. In Antiepileptic drugs. D. M. Woodbury, J. K. Penry & E. C. Pippenger, Eds. Raven Press. New York .pp. 611–616. 2 Reynolds, E. H. 1976. Folate and epilepsy. In Biochemistry and Neurology. H.F. Bradford & C.-D. Marsden, Eds. Academic Press. London , New York , San Francisco .pp. 247–252. 3 Caspers, H. & E. J. Speckmann. 1969. DC potential shifts in paroxysmal states. In Basic Mechanisms of the Epilepsies. H. H. Jasper, A. A. Ward & A. Pope, Eds. Little, Brown & Co. Boston .pp. 375–388. 4 Krause, K.-H., P. Berlit & J.-P. Bonjour. 1982. Erniedrigung des Biotins als möglicher Faktor im Wirkmechanismus von Antiepileptika. Arch. Psychiatr. Nervenkr. 231: 141–148. 5 Krause, K. H., P. Berlit & J.-P. Bonjour. 1982. Impaired biotin status in anticonvulsant therapy. Ann. Neurol. 12: 485–486. 6 Frigg, M. & G. Brubacher. 1976. Biotin deficiency in chicks fed a wheat based diet. Int. J. Vit. Nutr. Res. 46: 314–321. 7 Krause, K.-H. 1983. Biotin-Erniedrigung unter antiepileptischer Behandlung. Ein Beitrag zur moglichen Wirkungsweise von Antikonvulsiva. Hochschul-Verlag , Freiburg . 8 Bonjour, J.-P. 1977. Biotin in man's nutrition and therapy—a review. Int. J. Vit. Nutr. Res. 47: 107–118. 9 Bonjour, J.-P. 1981. Biotin-dependent enzymes in inborn errors of metabolism in humans. Wld. Rev. Nutr. Diet. 38: 1–88. 10 Mock, D. M., A. A. De Lorimer, W. M. Liebmann, L. Sweetman & H. Baker. 1981. Biotin deficiency. An unusual complication of parenteral alimentation. N. Engl. J. Med. 304: 820–823. 11 Sweetman, L., L. Suhr, H. Baker, R. M. Peterson & W. L. Nyhan. 1981. Clinical and metabolic abnormalities in a boy with a dietary deficiency of biotin. Pediatrics 68: 553–558. 12 Krause, K.-H., W. Kochen, P. Berlit & J.-P. Bonjour. 1984. Excretion of organic acids associated with biotin deficiency in chronic anticonvulsant therapy. Int. J. Vit. Nutr. Res. 54: 217–222. 13 Noll, F. 1974. L-Lactat. Bestimmung mit LDH, GPT und NAD. In Methoden der enzymatischen Analysen, 3rd edit. H.U. Bergmeyer, Ed. Verlag Chemie. Weinheim Vol. 3: 1521–1526. 14 Krause, K.-H., P. Berlit, J.-P. Bonjour, H. Schmidt-Gayk, B. Schellenberg & J. Gillen. 1982. Vitamin status in patients on chronic anticonvulsant therapy. Int. J. Vit. Nutr. Res. 52: 375–385. 15 Patel, M. S. 1974. The relative significance of CO2-fixing enzymes in the metabolism of rat brain. J. Neurochem. 22: 717–724. 16 Woodbury, D. M. & R. Karler. 1960. The role of carbon dioxide in the nervous system. Anesthesiology 21: 686–703. 17 Woodbury, D. M., L. T. Rollins, M. D. Gardner, W. L. Hirschi, J. R. Hogan, M. L. Rallison, G. S. Tanner & D. A. Brodie. 1958. Effects of carbon dioxide on brain excitability and electrolytes. Am. J. Physiol. 192: 79–90. 18 Woodbury, D. M. 1980. Phenytoin: Proposed mechanisms of anticonvulsant action. In Antiepileptic Drugs: Mechanisms of Action. G. H. Glaser, J. K. Penry & D. M. Woodbury, Eds. Raven Press. New York .pp. 447–471. 19 Glaser, G. H. 1972. Diphenylhydantoin toxicity. In Antiepileptic Drugs. D. M. Woodbury J. K. Penry & R. P. Schmidt Eds. Raven Press, New York . pp. 219–226. 20 Wolf, B., E. P. Paulsen & F. E. Dreifuss. 1981. Valproate in the treatment of seizures associated with propionic acidemia. Pediatrics 67: 162–163. 21 Lehnert, W., H. Niederhoff, A. Junker, H. Saule & W. Frasch. 1979. A case of biotin-responsive 3-methyl-crotonylglycin- and 3-hydroxyisovaleric aciduria. Eur. J. Pediatr. 132: 107–114. 22 Paulsen, E. P. & Y. E. Hsia. 1974. Asymptomatic propionic acidemia: Variability of clinical expression in a Mennonite kindred. Am. J. Hum. Genet. 26: 66A. 23 Sweetman, L., W. L. Nyhan, N. A. Sakati, A. Ohlsson, M. S. Mange, R. B. Boychuk & R. Kaye. 1982. Organic riciduria in neonatal multiple carboxylase deficiency. J. lnher. Metab. Dis. 5: 49–53. 24 Thoene, J., H. Baker, M. Yoshino & L. Sweetman. 1981. Biotin-responsive carhoxylase deficiency associated with subnormal plasma and urinary biotin. N. Engl. J. Med. 304: 817–820. 25 De Vivo, D. C., M. W. Haymond, M. P. Leckie, Y. L. Bussmann, D. B. McDougal & A. S. Pagliara. 1977. The clinical and biochemical implications of pyruvate carboxylase deficiency. J. Clin. Endocr. Metab. 45: 1281–1296. 26 Achuta Murthy, P. N. & S. P. Mistry. 1977. Biotin. Prog. Food Nutr. Sci. 2: 405–455. 27 Patsalos, P. N. & P. T. Lascelles. 1981. Changes in regional brain levels of amino acid putative neurotransmitters after prolonged treatment with the anticonvulsant drugs diphenylhydantoin, phenobarbitone, sodium valproate, ethosuximide, and sulthiame in the rat. J. Neurochem. 36: 688–4195. 28 Blass, J. P. 1979. Disorders of pyruvate metabolism. Neurology 29: 280–286. 29 Sander, J. E., S. Packmann & J. J. Townsend. 1982. Brain pyruvate carboxylase and the pathophysiology of biotin-dependent diseases. Neurology 42: 878–880. 30 Munoz-Garcia, D., T. Del Ser, F. Bermejo & A. Portera. 1982. Truncal ataxia in chronic anticonvulsant treatment. Association with drug-induced folate deficiency. J. Neurol. Sci. 55: 305–311. 31 Blank, N. K., R. N. Nishimura & F. J. Seil. 1982. Phenytoin neurotoxicity in developing mouse cerebellum in tissue culture. J. Neurol. Sci. 55: 91–97. 32 Iivanainen, M., M. Viukari & E.-P. Helle. 1977. Cerebellar atrophy in phenytoin-treated mentally retarded epileptics. Epilepsia 18: 375–386. 33 Meinardi, H. & L. M. K. Stoel. 1974. Side-effects of antiepileptic drugs. In Handbook of Clinical Neurology. P. J. Vinken & G. W. Bruyn, Eds. North-Holland, Publishing Comp., Amsterdam . Vol. 15: 705–738. 34 Ghatak, N. R., R. A. Santoso & W. M. McKinney. 1976. Cerebellar degeneration following long-term phenytoin therapy. Neurology 26: 818–820. 35 McLain, L. W., J. T. Marin & J. H. Allen. 1980. Cerebellar degeneration due to chronic phenytoin therapy. Ann. Neurol. 7: 18–23. 36 Selhorst, J. B., B. Kaufmann & S. J. Horwitz. 1972. Diphenylhydantoin-induced cerebellar degeneration. Arch. Neurol. 27: 453–455. 37 Schmidt, D. 1981. Behandlung der Epilepsien. Thieme Verlag, Stuttgart , New York . 38 Berlit, P., K.-H. Krause, C. C. Heuck & B. SchellenberC. 1982. Serum lipids and anticonvulsants. Acta Neurol. Scand. 66: 328–334. 39 Sydenstricker, V. P., S. A. Singal, A. P. Briggs, N. M. De Vaughn & H. Isbell. 1942. Observations on the “egg white injury” in man. JAMA 118: 1199–1200. 40 Scorn, D. 1958. Clinical biotin deficiency (“egg white injury”). Report of a case with some remarks on serum cholesterol. Acta Med. Scand. 162: 69–70. 41 Cowan, M. J., D. W. Wara, S. Packman, A. J. Ammann, M. Yoshino, L. Sweetman & W. L. Nyhan. 1979. Multiple biotin-dependent carboxylase deficiencies associated with defects in T-cell and B-cell immunity. Lancet ii: 115–118. 42 Sander, J. E., N. Malmud, M. J. Cowan, S. Packmann, A. J. Amman & D. W. Wera. 1980. Intermittent ataxia and immunodeficiency with multiple carboxylase deficiencies: a biotin-responsive disorder. Ann. Neurol. 8: 544–547. 43 Munnich, A., A. Fischer, J. M. Saudubray, C. Griscelli, F. X. Coude, H. Ogier, C. Charpentier & J. Frezel. 1981. Biotin-responsive immunregulatory dysfunction in multiple carboxylase deficiency. J. Inher. Metab. Dis. 4: 113–114. 44 Watanabe, T. 1983. Teratogenic effects of biotin deficiency in mice. J. Nutr. 113: 574–581. Citing Literature Volume447, Issue1BiotinJune 1985Pages 297-313 ReferencesRelatedInformation